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http://dxObjective: Recently, there has been increased interest in minimally invasive mitral valve prolapse repair
techniques; however, these techniques have limitations. A new technique was developed for treating mitral
valve prolapse that uses a novel leaflet plication clip to selectively plicate the prolapsed leaflet segment.
The clip’s efficacy was tested in an animal model.
Methods: Yorkshire pigs (n¼ 7) were placed on cardiopulmonary bypass (CPB), and mitral valve prolapse was
created by cutting chordae supporting the P2 segment of the posterior leaflet. Animals were weaned off CPB and
mitral regurgitation (MR) was assessed echocardiographically. CPB was reinitiated and the plication clip
was applied under direct vision to the P2 segment to eliminate the prolapse. The animals survived for 2 hours.
Epicardial echocardiography was obtained before and after prolapse creation and 2 hours after clip placement to
quantify MR grade and vena contracta area. Posterior leaflet mobility and coaptation height were analyzed
before and after clip placement.
Results: There were no cases of clip embolization. MedianMR grade increased from trivial (0-1.5) to moderate-
severe after MR creation (2.5-4þ) (P<.05), and decreased to mild after clip placement (0-3þ) (P<.05). Vena
contracta area tended to increase after cutting the chordae and decrease after clip placement: 0.08  0.10 cm2
versus 0.21  0.15 cm2 versus 0.16  0.16 cm2 (P ¼ .21). The plication clip did not impair leaflet mobility.
Coaptation height was restored to baseline: 0.51  0.07 cm versus 0.44  0.18 cm (P ¼ 1.0).
Conclusions: The leaflet plication clip can treat mitral valve prolapse in an animal model, restoring coaptation
height without affecting leaflet mobility. This approach is a simple technique that may improve the effectiveness
of beating-heart and minimally invasive valve surgery. (J Thorac Cardiovasc Surg 2014;147:783-91)Video clip is available online.
Mitral regurgitation (MR) is one of the leading valve-
related indications for cardiac surgery, with degenerative
mitral valve disease being the predominant pathology.1e Departments of Cardiac Surgerya and Cardiology,b Boston Children’s
ital, Harvard Medical School, Boston, Mass; and Department of Pediatric
ology,c Kardiozentrum, La Paz, Bolivia.
rk was support by the National Heart, Lung and Blood Institute (NIH) Award
5R01HL073647: ‘‘Image-guided Intracardiac Beating-Heart Surgery’’
.N.). The equipment and technology used in the study were purchased using
mic funds.
ures: Franz Freudenthal is employed by PFM Bolivia, the manufacturer of the
e prototype. The authors had full control of the design of the studies, methods
outcomemeasurements, analysis of data, and production of thewritten report.
ther authors have nothing to disclose with regard to commercial support.
t the 93rd Annual Meeting of The American Association for Thoracic
ery, Minneapolis, Minnesota, May 4-8, 2013.
d for publication May 5, 2013; revisions received Sept 12, 2013; accepted for
cation Sept 19, 2013; available ahead of print Nov 11, 2013.
for reprints: Nikolay V. Vasilyev, MD, Department of Cardiac Surgery,
n Children’s Hospital, HarvardMedical School, 300 Longwood Ave, Boston,
2115 (E-mail: nikolay.vasilyev@childrens.harvard.edu).
23/$36.00
ht  2014 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2013.09.044
The Journal of Thoracic and Ca
E
T
/B
SProlapse of the middle scallop of the posterior leaflet (P2)
caused by chordal elongation or rupture is the most com-
mon lesion seen in degenerative mitral valve disease.2
The conventional surgical technique for repair of mitral
valve prolapse (MVP) involves resection of the prolapsed
posterior leaflet segment along with a mitral annuloplasty,
as described by Carpentier.3 In addition, folding valvulo-
plasty techniques have recently been revisited and are
viewed by some as a preferred method of MVP repair,
particularly in the setting of minimally invasive mitral valve
surgery.4-7 Surgical repair of MVP is effective, durable, and
safe: 10-year freedom from reoperation exceeds 90% and
perioperative mortality approximates 0.5%.8,9 However,
there are patients who are not candidates for conventional
heart surgery and cardiopulmonary bypass (CPB).10-13 For
this cohort, minimally invasive and beating-heart mitral
valve repair techniques and devices have an important
role, offering the opportunity for valve repair while avoid-
ing the potential risks associated with heart surgery and
CPB. Emerging devices address the components of the
mitral apparatus, including the leaflets, annulus, and chor-
dae tendineae.14 Most notable is the MitraClip (Abbott
Vascular, Inc, Menlo Park, Calif), a transcatheter device
that treats MR by mimicking a surgical edge-to-edge repair.
Although the MitraClip has been one of the mostrdiovascular Surgery c Volume 147, Number 2 783
Abbreviations and Acronyms
ANOVA ¼ analysis of variance
CH ¼ coaptation height
CPB ¼ cardiopulmonary bypass
IACUC ¼ Institutional Animal Care and Use
Committee
ICC ¼ intraclass correlation coefficients
LPC ¼ leaflet plication clip
MVP ¼ mitral valve prolapse
VCA ¼ vena contract area
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Sextensively tested and used devices, this technology has
been used predominantly in patients with ischemic MR.
Therefore, there remains a need for alternative mitral valve
repair devices to address myxomatous mitral valve disease
and expand the versatility and effectiveness of minimally
invasive and beating-heart mitral valve surgery.
In an effort to answer this unmet need, a new technique of
leaflet plication was developed that uses a novel leaflet
plication clip (LPC) to treat MVP. The LPC folds
(or plicates) the prolapsed leaflet segment without involving
the neighboring leaflet segments or the anterior leaflet.
Although the ultimate goal is to implant the LPC in
minimally invasive procedures, including image-guided
beating-heart techniques, the aim of the present study was
to test the clip’s performance and short-term efficacy for
treating MVP using open surgery in an animal model.MATERIALS AND METHODS
Device Overview
The LPC is composed of a folded nickel-titanium alloy (nitinol) wire
that is 0.45 mm in diameter. The device has a central loop and 2 sharpened
ends distally (Figure 1, A). It has a closed resting state and can be opened to
expose the sharpened tips and incorporate the entire prolapsed leaflet
segment during implantation (Figure 1, B and C). For the current study,
the clip measuring 11 mm in length and 3 mm in width in its resting state
was used in all cases, except 1 where a larger clip was used. In its open
state, the clip tips are approximately 6 mm apart, which defines the amount
of leaflet tissue that is plicated. Clips can be manufactured in a range of
sizes to plicate varying amounts of tissue. A specialized, hand-held
deployment device was developed that engages the LPC and can open/
close the device for implantation (Figure 1, D).
Device implantation involves the following steps (Figure 2, Video 1):
1. Open the LPC, which is mounted on the tip of the deployment device
(Figure 1, D, arrow).
2. Direct the distal clip arms toward the belly of the prolapsed leaflet
segment with the device oriented perpendicular to the leaflet hinge
point.
3. Puncture the prolapsed segment midway between the leaflet hinge point
and the free edge.
4. Advance the LPC until the proximal elbow abuts the leaflet tissue.
5. Close the LPC, which folds/plicates the involved leaflet tissue into the
device.
6. Disengage the LPC from the deployment device. The clip remains in its
closed state due to the shape memory of the nitinol material.784 The Journal of Thoracic and Cardiovascular SurgThe clip that was used in this study does not involve the annular tissue. It
solely plicates the leaflet tissue between the midbelly and the free edge of
the leaflet. This positioning allows for leaflet plication without affecting
annular geometry. Notably, the LPC can be removed and reinserted without
causing significant leaflet trauma, thus allowing for repositioning in cases
of suboptimal clip implantation.
Investigational Protocol
The experimental protocolwas approved by theBostonChildren’sHospital
Institutional Animal Care and Use Committee (IACUC). All animals received
humane care in accordance with the 1996 Guide for the Care and Use of
Laboratory Animals recommended by the US National Institutes of Health.
Yorkshire female pigs (60-73 kg, n ¼ 7) were anesthetized using
intramuscular injection of telazol (4.4 mg/kg), xylazine (2.2 mg/kg), and
atropine (0.04 mg/kg), and then intubated with a cuffed endotracheal
tube and ventilated with a volume-control ventilator (Fabius Tiro; Draeger
Medical, Andover, Mass). Anesthesia was maintained with inhaled
desflurane (4%-9%). A transurethral urinary catheter was inserted for
monitoring of urine output. Arterial and central venous lines were placed
percutaneously in the left femoral artery and vein for arterial and central
venous pressure monitoring, respectively. Electrocardiography and
temperature monitoring were accomplished via esophageal and rectal
probes, respectively. A right groin incision was made and the right femoral
artery was exposed for arterial cannulation. After administration of
intravenous cisatrocurium (0.1 mg/kg), a left posterolateral thoracotomy
was performed through the fourth intercostal space. Stay sutures were
placed in the pericardium to optimize access to the left atrial appendage,
and a baseline two-dimensional (2D) and three-dimensional (3D)
epicardial echocardiogram was performed. After intravenous heparin
administration (300 U/kg) to achieve an activated clotting time of
>350 seconds, arterial cannulation was performed via the right femoral
artery using an 18F cannula. Venous cannulation was achieved via the right
atrial appendage with a 34F straight, single-stage cannula. CPB was
initiated using an oxygenator (FX25; Terumo Medical Corporation,
Somerset, NJ). Fentanyl (50-200 m/kg) and midazolam (0.2 mg/kg) were
administered for anesthesia during CPB. The animals were cooled to
32C, at which point the ascending aorta was crossclamped and cold
cardioplegia solution (del Nido cardioplegia solution) was delivered in
an anterograde fashion via the aortic root.15 After cardiac arrest, the left
atrial appendage was opened and suspended upward with stay sutures to
expose the mitral valve. Valve competence was assessed by cold saline
injection. Then primary marginal and secondary chordae tendineae
supporting the P2 segment of the posterior mitral leaflet were cut,
mimicking chordal rupture andMVP/flail. MVPwas confirmed with repeat
cold saline injection, after which the left atrial appendage was closed. The
animals were rewarmed, the heart was deaired, and the aortic crossclamp
was removed. After weaning off CPB, repeat 2D/3D epicardial echocardi-
ographywas performed to document valve function. The animals were then
placed back on CPB and cooled to 32C. The ascending aorta was again
crossclamped and the heart was arrested in the same manner as before.
The left atrial appendage was reopened, and after examining the prolapsed
P2 segment, the LPCwas applied under direct vision to repair the prolapse.
Repeat cold saline injection was administered to assess device position and
valve competence. The left atriotomywas then closed and the animals were
rewarmed. After deairing, the aortic crossclamp was removed, the animals
were weaned off CPB, and the cannulae were removed. 2D/3D epicardial
echocardiography was repeated 2 hours after discontinuing CPB. The
animals were then euthanized by intravenous injection of overdosed pento-
barbital sodium (Fatal-Plus; Vortech Pharmaceuticals, Dearborn, Mich; 86
mg/kg). The heart was then excised and opened for direct inspection.
Echocardiographic Measurement and Analysis
Epicardial 2D and 3D echocardiograms were obtained at 3 time points:
(1) before MVP creation, (2) after MVP creation, and (3) 2 hours after clipery c February 2014
FIGURE 1. Leaflet plication clip and deployment device. A, Resting state of leaflet plication clip. B, Leaflet plication clip mounted on the deployment
device in closed/resting state. C, Leaflet plication clip in open state. D, Deployment device; leaflet plication clip mounts on its tip. Asterisk indicates the
central loop of the leaflet plication clip; the arrowhead indicates the sharpened arms of the leaflet plication clip; the arrow indicates the tip of the
deployment device where the clip is mounted. The ruler indicates 1-mm marks.
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Simplantation. All echocardiograms were obtained with animals completely
off CPB using a matrix array probe X7-2 (2-7 MHz) on an iE33 system
(Philips Healthcare, Andover, Mass). Echocardiographic imaging was
analyzed by 2 investigators who were blinded to animal and time point
identification.
The severity of MR was graded according to the extent of the color
Doppler regurgitant jet visualized on 2D color Doppler imaging. MR grade
was categorized as none (0), trivial (1þ), mild (2þ), moderate (3þ), or
severe (4þ). Intermediate gradings were defined by intervals of 0.5
(eg, 2.5 ¼ mild to moderate). Color Doppler and noncolor 3D images
were acquired in the full-volume acquisition mode and then analyzed
offline using the multiplanar 3D quantification mode in Qlab software,
Version 8.1 (Philips Healthcare, Andover, Mass). Vena contract area
(VCA) of the MR jet was measured before MR creation, after MR creation,
and 2 hours after device implantation. VCAwas measured at the frame in
systole where MR was felt to be the greatest, as described elsewhere.16
Coaptation height (CH) was analyzed in cases where an optimal
functional result was obtained with the LPC. The purpose of this analysis
was to determine whether normal CH could be restored by the clip in casesThe Journal of Thoracic and Caof device success. CH was analyzed at midsystole by obtaining a
cross-sectional plane through the A2-P2 region of the mitral valve, and
then measuring the height of leaflet coaptation (Figure 3, A).
Posterior mitral leaflet mobility was analyzed to assess whether the LPC
restricted posterior leaflet motion and impaired valve function. To assess
leaflet mobility, the posterior leaflet was examined in a cross-sectional
plane through the P2 segment. At midsystole, the angle between the mitral
annular plane and the plane through the belly of P2 was determined (qs)
(Figure 3, B). The same was done at maximal leaflet opening during
diastole (qd) (Figure 3, C). The change in this angle between midsystole
and maximal diastolic leaflet opening (qd  qs) was defined as Dq, and
was used to quantify the degree of posterior leaflet mobility.
Statistical Analysis
Ordinal data (eg, MR grade) are reported as median (interquartile
range). Continuous measures (eg, VCA, CH, leaflet mobility) are reported
as mean standard deviation. For ordinal data, comparisons between time
points were made using a Friedman repeated-measures analysis of variance
(ANOVA) on ranks. If ANOVA yielded a statistically significant resultrdiovascular Surgery c Volume 147, Number 2 785
FIGURE 2. En face view of the mitral valve and leaflet plication clip (LPC) placement: left ventricle pressurized in a water-tank setup to test valve
competence (A, B, and F). A, Baseline, competent mitral valve with normal P2 segment. B, P2 prolapse/flail created by 1 and 2 chordae cutting.
C, LPC opened. D, LPC applied to prolapsed P2 segment. E, LPC closed, P2 segment plicated. F, Restored mitral valve competence with elimination of
P2 prolapse/flail. Curved arrows indicate the motion of LPC closure and leaflet plication. The straight arrow indicates the hub of the LPC in the final state;
the body of the LPC is below the coaptation line in the final resting state.
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S(P<.05) then a post hoc analysis of ordinal data was accomplished using a
Wilcoxon signed ranks test. For continuous variables, a one-way repeated-
measures ANOVAwas done for data that passed the normality and equal
variance tests. If ANOVA yielded a statistically significant result
(P<.05) then a post hoc test was done using the Bonferroni correction.
Interobserver variability for measurements of MR grade and vena contracta
area was determined by analysis of 7 randomly selected studies that were
reviewed by 2 independent blinded observers. The results were assessed
using intraclass correlation coefficients (ICC). Data were analyzed using
IBM SPSS Statistics, Version 21.0 (IBM Corp, Armonk, NY).RESULTS
Surgical Characteristics and Results
All animals survived the surgical procedure. After
assessing baseline valve competence with cold saline injec-
tion, chordae tendineae supporting P2 were cut sequentially
starting with the primary marginal chordae supporting the
central portion of the P2 free edge. Repeat cold saline injec-
tion was then performed to assess valve competence. If the
valve was still competent after primary chordae cutting,
then secondary chordae supporting the belly of P2 were
cut. In all cases, chordae supporting the P1-P2 and P2-P3
junctions were kept intact, thereby creating flail only in
the central portion of the P2 scallop, with chordal support
along the P2 margins. Between 2 and 4 primary and second-
ary chordae were cut in each case. Echocardiographically,
the regurgitant jet was directed anteriorly over A2,
consistent with the P2 prolapse/flail that had been created
(Figure 4). One animal required an additional CPB run
because there was insufficient MR on echocardiography
after chordae cutting during the first bypass run. This animal
was ultimately left with severe (4þ) MR after additional
chordae cutting.786 The Journal of Thoracic and Cardiovascular SurgOne LPCwas implanted in each animal. All clip implanta-
tions were accomplished without significant tissue trauma
(eg, leaflet tears, chordal lacerations). There were no
incidents of device embolization, as confirmed by postopera-
tive echocardiograms anddirect examination at explant; how-
ever, there were 2 cases where the clip moved slightly from
the implantation position. In 1 case, the clip seemed to be
caught on underlying secondary chordae, which then limited
A2-P2 leaflet coaptation. This animal had the lowest baseline
CH, which also contributed to the residual MR. In another
case, the clip’s orientation changed after implantation,
shifting to amore oblique position relative to the leaflet hinge
point. This led to persistent A2-P2 malcoaptation. There was
no evidence of clot formation on or around the device in any
of the animals at the time of explant.
LPC Performance
MedianMR grade at baseline was trivial (0-1.5). In 5 of 7
cases, at least moderate-severe MR was created by chordae
cutting. In the remaining 2 cases, mild and mild-moderate
MR were induced. The median MR grade after chordae
cutting was moderate-severe (2.5-4þ), which was signifi-
cantly increased from baseline (P ¼ .018). MR grade
decreased significantly after clip placement, with a median
MR grade of mild (0-3þ) at 2 hours after surgery
(P ¼ .027). This final MR grade was not statistically
different from baseline (P ¼ .102) (Figure 5, A). The 2
animals found to have improper device position at explant
each had moderate (3þ) MR 2 hours after clip implantation.
This was slightly improved from the moderate-severe (3.5)
and severe (4þ) MR they had after chordae cutting but
before clip implantation.ery c February 2014
FIGURE 3. Echocardiographic images depicting measurements of
coaptation height and posterior mitral leaflet mobility. A, Coaptation height
(CH) measured after obtaining the cross-sectional plane in the A2-P2
region during midsystole. B, qs is the angle between the plane of the mitral
annulus and the plane of the P2 leaflet at midsystole. C, qd is the angle
between the plane of the mitral annulus and the plane of the P2 leaflet at
maximal leaflet opening. Dq ¼ qd  qs quantifies the degree of posterior
leaflet (PL) mobility during the cardiac cycle. AL, Anterior leaflet.
FIGURE 4. 2D color Doppler imaging of MR grade from 1 animal.
A, Preoperative/baseline trivial-mild MR. B, Severe MR after chordae
cutting, with the jet directed over the anterior leaflet consistent with
P2 prolapse/flail. C, Restored mitral valve competence after leaflet
plication clip implantation. Red arrow indicates the leaflet plication clip
(note shadow imaging artifacts above and below the clip. LA, Left atrium;
LV, left ventricle.
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SVCA tended to increase after chordae cutting and
decrease after placement of the LPC; however, these
changes were not statistically significant (F(2,12) ¼ 1.791,
P ¼ .209) (Figure 5, B). In those cases where an optimal
functional outcome was attained, the LPC restored
coaptation height to baseline: baseline CH ¼ 0.51  0.07
cm versus 0.44  0.18 cm after clip implantation
(P ¼ 1.0) (Figure 5, C). Leaflet mobility was not signifi-
cantly altered by the LPC: baselineDq¼ 45.8 4.3 versus
42.2 11.0 after clip implantation (P¼ 1.0) (Figure 5,D).Observer Variability
Excellent correlation was observed in the interobserver
variability of echocardiographic measurements. ICC for
MR grade was 0.980 (95% confidence interval [CI],
0.890-0.997). ICC for vena contracta area was 0.972
(95% CI, 0.857-0.995).The Journal of Thoracic and CaDISCUSSION
The clinical sequelae of MR are well known and surgical
repair is widely accepted.17 Conventional surgical repair
techniques have dramatically improved over the past
several decades and current surgical outcomes are excel-
lent.8,9,18 There remains, however, a cohort of patientsrdiovascular Surgery c Volume 147, Number 2 787
FIGURE 5. Longitudinal data for MR grade, vena contracta area,
coaptation height, and posterior mitral leaflet mobility. A, Median MR
grade; implantation of the leaflet plication clip (LPC) resulted in a
statistically significant decrease in MR grade; the final MR grade was
similar to the baseline MR grade. B, Vena contracta area tended to increase
after chordae cutting and decreased after LPC implantation. C, Coaptation
height was restored to baseline by the LPC. D, Posterior mitral leaflet
mobility was not significantly altered by the LPC. For MR grade, data
are presented as the median, error bars indicate the interquartile
range. For vena contracta area, coaptation height, and leaflet mobility,
data are presented as means, error bars indicate standard deviation.
Pre, Preoperative; Post, post-MR creation; NS, not significant; MR, mitral
regurgitation.
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Swhose operative risk precludes conventional heart
surgery.19 For these high-risk patients, emerging minimally
invasive and beating-heart mitral valve repair techniques
and technology offer an important alternative.
For myxomatous disease, in particular, use of the
MitraClip as well as chordal replacement devices have
been described. The MitraFlex (TransCardiac Therapeutics
LLC, Atlanta, Ga) and the NeoChord (NeoChord, Inc.,
Minnetonka, Minn) use a transapical approach for
artificial chordae implantation.20 The Babic device uses a
combined transapical and transseptal approach for chordae
implantation.21
The novel device presented in this article aims to broaden
the scope and enhance the effectiveness of minimally
invasive MVP repair by enabling an alternative method of
leaflet repair: leaflet plication. The novel LPC selectively
folds the prolapsed leaflet segment without involving the
adjacent, normal leaflet tissue, as is required with edge-to-
edge repair techniques. The present study is the first to
test the LPC in vivo. It was conducted under open surgical
conditions to specifically assess the clip’s performance
without the confounding effect of experimental image-
guided and/or minimally invasive LPC deployment
methods. This study demonstrated that the LPC can suc-
cessfully restore leaflet coaptation and valve competence
by functionally excluding the prolapsed leaflet segment.
Moreover, because of the LPC’s low profile, normal valve
dynamics (eg, leaflet mobility) are preserved. The clip’s
low profile also minimizes thrombogenicity because most
of the device is covered by leaflet tissue. Thus, the LPC
could make minimally invasive folding mitral valvuloplas-
ties more feasible and reproducible.
In this initial in vivo study, there was some variation in
device performance. Although all animals experienced
statistically significant improvement in MR grade after
clip placement, 3 animals were left with moderate MR
and 4 were left with zero to mild MR. The possible
mechanisms underlying the 3 suboptimal outcomes relate
to: (1) preoperative valve characteristics and (2) device
implantation/function.
Preoperative Valve Characteristics
Baseline leaflet coaptation seemed to influence device
performance; animals with minimal A2-P2 coaptation
preoperatively tended to have suboptimal results. Animals
with significant baseline coaptation had more successful
repairs. This finding is likely related to one of the limita-
tions in theMR creation model. By cutting chordae support-
ing the central portion of P2, this model successfully
created P2 segment flail; however, this does not perfectly
mimic leaflet prolapse. Moreover, this model did not repro-
duce the characteristics of a degenerative/myxomatous
mitral valve, with excessive/redundant valve tissue.22
Consequently, in animals with minimal baseline coaptation,ery c February 2014
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SP2 plication may have excessively reduced the posterior
leaflet surface area to the point where valve competence
was impaired. The current study did not have sufficient
imaging acquisition to assess leaflet surface area and
quantitatively analyze its effect on device performance. It
is possible that a minimum leaflet surface area to valve
orifice area ratio exists that is required for the clip to be
successful. This is the focus of future work.
Device Implantation and Function
In 2 of the 3 animals left with moderate MR, clip
implantation and function were suboptimal. In 1 case, direct
examination on explant revealed that the LPC was caught
on underlying secondary chordae. Because the device
punctures the leaflet belly and passes along the ventricular
surface of the leaflet, it is crucial to ensure that the clip
arms do not catch underlying secondary and/or strut
chordae. This is accomplished by gently grasping the P2
scallop from the anterior and posterior points of its
free edge, suspending it away from the underlying
ventricular endocardial surface, and flattening it out during
implantation. As the clip is advanced into the leaflet, it is
kept parallel to the leaflet plane to avoid entangling
underlying structures. These important details of device
implantation will be incorporated into future design
iterations that target beating-heart implantation.
In the case where the LPC shifted obliquely after
implantation, it is likely that the clip was not implanted
perpendicular to the annulus, and that subsequent
intracardiac forces acted asymmetrically on the clip,
pushing it into an oblique position. When the clip lies
obliquely, it pulls the P2 leaflet tissue away from the
coaptation line, thereby preventing P2-A2 coaptation.
This underscores the importance of the clip being oriented
perpendicular to the leaflet hinge point at the time of
implantation. Current work is focusing on a more advanced
locking system for the clip, which will provide even greater
fixation to the leaflet tissue and prevent clip migration.
A concurrent reduction annuloplasty was not performed.
Annuloplasty was excluded in an effort to analyze the effect
of the LPC in isolation. Furthermore, leaflet flail was
created only in the central portion of P2 to avoid excessive
leaflet plication, which might distort annular geometry
and necessitate a sliding annuloplasty. Future work will
address the effectiveness of the LPC when a concurrent
annuloplasty is performed, as this may further improve
the functional outcome after clip implantation. This will
be particularly relevant given the development of trans-
catheter mitral annuloplasty devices that could ultimately
be used in conjunction with the LPC.23
The ultimate goal is to achieve leaflet plication and
MVP repair by using beating-heart, image-guided clip
implantation techniques. However, it should be recognized
that the LPC has potential applications outside minimallyThe Journal of Thoracic and Cainvasive or beating-heart mitral valve repair. The clip’s
simple and reproducible plication of the prolapsed leaflet
segment makes it an attractive alternative in conventional
heart surgery, which often entails complex leaflet repairs.
Moreover, the reversibility of the clip allows the surgeon
to remove and reposition the clip if intraoperative valve
testing demonstrates a suboptimal result. This reversibility
gives the surgeon greater versatility and flexibility
compared with conventional, suture-based leaflet resection
techniques.
The present study is limited to a short-term evaluation of
the performance of the LPC for treating MVP. Chronic
in vivo studies are necessary to assess the long-term
performance of the device. In particular, evidence of device
migration and the local tissue response to the LPC will be
assessed. Future studies will also focus on valve anatomy
to determine the anatomic characteristics that lead to
optimal device performance. For example, understanding
the maximum width of prolapse/flail that can be treated
with the LPC will be important for determining
anatomic indications and contraindications to its use.
Also, determining whether other segments of leaflet
prolapse (eg, P1, P3, anterior leaflet) can be treated with
this clip will be important.
In conclusion, this initial in vivo study demonstrates that
the LPC can effectively repair MVP in an animal model by
restoring normal coaptation without compromising leaflet
mobility. This technique and device have important
applications in a wide range of mitral valve therapies,
including conventional heart surgery, minimally invasive
mitral valve surgery, and image-guided beating-heart
interventions. These are early results, and there are
imperfections in the current device design that require
further development. Critical to the next steps is a chronic
animal model to better characterize longer-term device
behavior. In addition, future work will focus on specific
anatomic indications/contraindications, and developing
beating-heart methods of implantation. Accomplishing
this would broaden our technical armamentarium for mitral
valve repair and enhance our ability to repair MVP/MR in
high-risk surgical patients.
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Dr Valavanur Subramanian (New York, NY). Very elegant.
I have a few questions. How do you adjust your amount
of folding into your clip or do you have different sizes, number
one?
Dr Feins.We have multiple clip sizes that we use. For the pur-
poses of this in vivo study, we found that almost all animals except
1 required just the smallest size clip we have, which I can back up790 The Journal of Thoracic and Cardiovascular Surgto show you based on the scale from my slides. One animal did
require a larger clip.
The clips themselves are fairly fixed in the amount of leaflet
tissue that they can plicate, which you can see is probably defined
by the maximum opening state of the clip itself. However, it is a
fairly trivial matter to create variable size clips for the purposes
of plicating different amounts of leaflet tissue.
Dr Subramanian. In the animals, do you look at the flailed gap,
howmuch of a flailed gap you had before you had a successful clip
deployment?
Dr Feins. I’m sorry, could you repeat the question?
Dr Subramanian. The flailed gap, how much of a prolapse
from the annular plane, because there are limitations there.
Dr Feins.What we had tried to dowasmaintain the chordae that
were supporting the segments of the leaflet between the P2 and P3
scallops and the P1 and P2 scallops, with the goal of having some
leaflet tissue of P2 that still had chordal support so that when we
plicated the central segment we would have some supporting
leaflet tissue to maintain valve function.
Generally speaking, our goal was to create prolapse in just the
central portion of P2, which essentially was about 3 or 4 mm.
I would say between 3 and 5 mm in terms of the length of the
coaptation line for the valve itself.
Dr Song Wan (Shatin, Hong Kong). Congratulations for this
innovative design and excellent experimental result. I have one
comment and one question. The comment is, your idea appears
to me to be more advanced than MitraClip, however, it didn’t
overcome the intrinsic critical drawback of MitraClip, namely, it
only addresses the leaflet but not the annulus, and without proper
annuloplasty, the long-term durability is reduced, as all of us know
already.
The question is, your device seems more suitable for the
chronic, for example, P2 prolapse, with excessive valve tissue
and maybe myxomatous change. However, your animal model is
an acute model with chordal cutting, and the leaflets are more or
less normal in this setting. Do you think your device can be used
in acute MR, like a sudden rupture of the chordae, exactly mimic
your animal model?
DrFeins.Thank you for your comments and question. I certainly
think that there is some limitation to our animalmodel with regard to
the type of lesion that wewere creating. Not all prolapses are created
equal, and this is a very different lesion than a myxomatous valve
with excessive leaflet tissue. This is a limitation of our model.
You could envision various scenarios where you would create a
more clinically similar type of lesion, and that may involve
augmentation of the leaflet and then surviving animals to create a
dilated annulus that mimics the clinical scenario.
The purposes of this study were mainly to assess the clip in an
acute setting, not because this would necessarily be a replacement
to a chordal replacement, for example, but simply as a way of
seeing if the ex vivo findings that we had could be reproducible
in an acute model. And I suspect in the setting of what you are
describing, which is excessive leaflet tissue with redundancy,
which we see in a more chronic setting, that this leaflet plication
clip would arguably have even better results than in an acute
chordal rupture model.
And just in response to your comment, I completely agree. Our
intention for not including an annuloplasty was simply to assessery c February 2014
Feins et al Evolving Technology/Basic Sciencethe sole effect of the clip in isolation. I think we can all agree that
an annuloplasty in addition will improve outcomes. And while
the clip doesn’t add an annuloplasty, and in that way is not an
improvement on the current MitraClip, I think it is fair to say
that one of the reasons that mitral valve reparative surgery has
improved over the past several decades is due to the breadth of
reparative techniques we have: annuloplasty, edge-to-edge repair,
and the various ways to address the leaflet and the chordae. This
represents one way of doing that by plicating the leaflet rather
than simply involving the other leaflet segments.The Journal of Thoracic and CaDrMathewWilliams (New York, NY). What are your plans for
putting this in a catheter-based approach?
Dr Feins. We are currently developing some of the minimally
invasive methods for implanting this, and there is a wide range
of applications. I think when we developed this, we saw this not
just as a percutaneous or catheter-based technique. There are
also transcardiac ways of implanting it, as well as implantation
in the open heart. One could argue that in conventional heart sur-
gery, having a device such as this allows for a more reproducible
way of plicating the leaflet instead of suture-based techniques.rdiovascular Surgery c Volume 147, Number 2 791
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